drugset / Trial / NCT02716142
Rectal Misoprostol Versus Sublingual Misoprostol Prior to Myomectomy
RandomizedParallel-groupOpen-labelPrevention
Summary
the aim of the study is To compare the effectiveness of rectally administered prostaglandin E1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before myomectomy to decrease blood loss during and after the operation.
Timeline
- Start
- 2017-03-01
- Primary completion
- 2019-12-31
- Completion
- 2020-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Misoprostol | Other / unclassified | 400 ug | Rectal |
Indications
No indication recorded.